Case Report: Opposite Effects of BRAF Inhibition on Closely Related Clonal Myeloid Disorders

Langerhans cell histiocytosis (LCH) commonly co-occurs with additional myeloid malignancies. The introduction of targeted therapies, blocking “driver” mutations (e.g., BRAF V600E), enabled long-term remission in patients with LCH. The effect of BRAF inhibition on the course and the prognosis of co-e...

Descripción completa

Detalles Bibliográficos
Autores principales: Hostettler, Katrin E., Casañas Quintana, Elisa, Tamm, Michael, Savic Prince, Spasenija, Sommer, Gregor, Chen, Wei-Chih, Nordmann, Thierry Michael, Lundberg, Pontus, Stehle, Gregor Thomas, Daikeler, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739218/
https://www.ncbi.nlm.nih.gov/pubmed/35004300
http://dx.doi.org/10.3389/fonc.2021.779523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739218/
https://www.ncbi.nlm.nih.gov/pubmed/35004300
http://dx.doi.org/10.3389/fonc.2021.779523

Ejemplares similares